Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6234-6241

  Wennerås, Christine ^a   Qadri, Firdausi ^b   Bardhan, Prodeep K ^b   Sack, R Bradley ^b   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A; VACCINE;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MUCOSAL IMMUNITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; BACTERIAL PROTEINS; BACTERIAL VACCINES; DUODENUM; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; FEMALE; FIMBRIAE PROTEINS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; VACCINATION; VACCINES, INACTIVATED;

EID: 0032752560     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ahrén, C., M. Jerthorn, and A.-M. Svennerholm. 1998. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood. Infect. Immun. 66:3311-3316.
2. Ahrén, C., C. Wennerås, J. Holmgren, and A.-M. Svennerholm. 1993. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen Escherichia coli vaccine. Vaccine 11:929-934.
3. Ahrén, C. M., and A.-M. Svennerholm. 1982. Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens. Infect. Immun. 38:74-79.
4. Apter, F. M., P. Michetti, L. S. Winner III, J. A. Mack, J. J. Mekalanos, and M. R. Neutra. 1993. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect. Immun. 61:5279-5285.
5. Black, R. E. 1993. Epidemiology of diarrhoeal disease: implications for control by vaccines. Vaccine 11:100-106.
6. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, P. K. Neogy, B. Stanton, N. Huda, M. U. Khan, B. A. Kay, M. R. Khan, M. Ansaruzzaman, M. Yunus, M. R. Rao, A.-M. Svennerholm, and J. Holmgren. 1988. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale trial. J. Infect. Dis. 158:372-377.
7. Cravioto, A., R. E. Reyes, F. Trujillo, F. Uribe, A. Navarro, J. M. de la Roca, J. M. Hernández, G. Pérez, and V. Vázquez. 1990. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am. J. Epidemiol. 131:886-904.
8. Czerkinsky, C., L.-Å. Nilsson, H. Nygren, Ö. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 115:31-37.
9. Evans, D. G., F. J. de la Cabada, and D. J. Evans, Jr. 1982. Correlation between intestinal immune response to colonization factor antigen/I and acquired resistance to enterotoxigenic Escherichia coli diarrhea in an adult rabbit model. Eur. J. Clin. Microbiol. 1:178-185.
10. Ferguson, A., K. A. Humphreys, and N. M. Croft. 1995. Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading. Clin. Exp. Immunol. 99:70-75.
11. Gaastra, W., and A.-M. Svennerholm. 1996. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 4:444-452.
12. Helander, A., H. M. S. Grewal, W. Gaastra, and A.-M. Svennerholm. 1997. Detection and characterization of the coli surface antigen 6 of enterotoxigenic Escherichia coli by using monoclonal antibodies. J. Clin. Microbiol. 35:867-872.
13. Jertborn, M., C. Ahrén, J. Holmgren, and A.-M. Svennerholm. 1998. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. Vaccine 16:255-260.
14. Kantele, A., J. M. Kantele, H. Arvilommi, and P. H. Mäkelä. 1991. Active immunity is seen as a reduction in the cell response to oral live vaccine. Vaccine 9:428-431.
15. Levine, M. M., R. E. Black, M. L. Clements, C. R. Young, C. P. Cheney, P. Schad, H. Collins, and E. C. Boedeker. 1984. Prevention of enterotoxigenic Escherichia coli diarrheal infection in man by vaccines that stimulate anti-adhesion (anti-pili) immunity, p. 223-244. In E. C. Boedeker (ed.), Attachment of organisms to the gut mucosa, vol. II. CRC Press, Inc., Boca Raton, Fla.
16. Levine, M. M., D. R. Nalin, D. L. Hoover, E. J. Bergquist, R. B. Hornick, and C. R. Young. 1979. Immunity to enterotoxigenic Escherichia coli. Infect. Immun. 23:729-736.
17. Lopez-Vidal, Y., and A.-M. Svennerholm. 1990. Monoclonal antibodies against different subcomponents of colonization factor antigen II of enterotoxigenic Escherichia coli. J. Clin. Microbiol. 28:1906-1912.
18. Mattsson, A., H. Lönroth, M. Quiding-Järbrink, and A.-M. Svennerholm. 1998. Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J. Clin. Investig. 102:51-56.
19. McConnell, M. M., H. Chart, A. M. Field, M. Hibberd, and B. Rowe. 1989. Characterization of a putative colonization factor (PCFO166) of enterotoxigenic Escherichia coli of serogroup O166. J. Gen. Microbiol. 135:1135-1144.
20. McConnell, M. M., H. Chart, and B. Rowe. 1989. Antigenic homology within human enterotoxigenic Escherichia coli fimbrial colonization factor antigens: CFA/I, coli-surface-associated antigens (CS)1, CS2, CS4 and CS17. FEMS Microbiol. Lett. 61:105-108.
21. Ogra, P. L., and D. T. Karzon. 1969. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with polio vaccine. J. Immunol. 102:1423-1430.
22. Peltola, H., A. Siitonen, H. Kyrönseppä, I. Simula, L. Mattila, P. Oksanen, M. J. Kataja, and M. Cadoz. 1991. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338:1285-1289.
23. Quiding, M., I. Nordström, A. Kilander, G. Andersson, L. Å. Hanson, J. Holmgren, and C. Czerkinsky. 1991. Intestinal immune responses in humans: oral cholera vaccination induces strong intestinal antibody responses and interferon-γ production and evokes local immunological memory. J. Clin. Investig. 88:143-148.
24. Rudin, A., G. Wiklund, C. Wennerås, and F. Qadri. 1997. Infection with colonization factor antigen 1-expressing enterotoxigenic Escherichia coli boosts antibody responses against heterologous colonization factors in primed subjects. Epidemiol. Infect. 119:391-393.
25. Sanchez, J., and J. Holmgren. 1989. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA 86:481-485.
26. Savarino, S. J., F. M. Brown, E. Hall, S. Bassily, F. Youssef, T. Wierzba, L. Peruski, N. A. El-Masry, M. Safwat, M. Rao, M. Jertborn, A.-M. Svennerholm, Y. J. Lee, and J. D. Clemens. 1998. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J. Infect. Dis. 177:796-799.
27. Savarino, S. J., E. R. Hall, S. Bassily, F. M. Brown, F. Youssef, T. F. Wierzba, L. Peruski, N. A. El-Masry, M. Safwat, M. Rao, H. El Mohamady, R. Abu-Elyazeed, A. Naficy, A.-M. Svennerholm, M. Jertborn, Y. J. Lee, and J. D. Clemens. 1999. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. J. Infect. Dis. 179:107-114.
28. Stoll, B. J., A.-M. Svennerholm, L. Gothefors, D. Barua, S. Huda, and J. Holmgren. 1986. Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area. J. Infect. Dis. 153:527-534.
29. Svennerholm, A.-M., and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Curr. Microbiol. 1:19-23.
30. Svennerholm, A.-M., J. Holmgren, R. Black, M. Levine, and M. Merson. 1983. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J. Infect. Dis. 147:514-522.
31. Svennerholm, A.-M., M. Wikström, M. Lindblad, and J. Holmgren. 1986. Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GMI-enzyme-linked immunosorbent assay. J. Clin. Microbiol. 24:585-590.
32. Walker, W. A., and K. J. Isselbacher. 1972. Intestinal uptake of macromolecules: effect of oral immunization. Science 177:608-610.
33. Wennerås, C., A.-M. Svennerholm, and C. Czerkinsky. 1994. Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 62:874-879.
34. Wennerås, C., A.-M. Svennerholm, C. Åhrén, and C. Czerkinsky. 1992. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 60:2605-2611.
35. World Health Organization. 1990. Manual for the treatment of diarrhoea: for use by physicians and other senior health workers. CDD/SER/80.2 Rev 2. World Health Organization, Geneva, Switzerland.
36. Yokoyama, H., R. C. Peralta, R. Diaz, S. Sendo, Y. Ikemori, and Y. Kodama. 1992. Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets. Infect. Immun. 60:998-1007.